Choose your language
Pharma Business Development & Licensing Course
More than 2 million learners worldwide

Pharma Business Development & Licensing Course

4

Master the full spectrum of pharmaceutical business development, from asset valuation and due diligence to deal structuring and alliance management. This course equips BD professionals with the analytical frameworks, negotiation strategies, and governance tools used at top pharma companies. Whether you're evaluating your first licensing deal or managing a multi-asset portfolio, you'll gain the skills to drive real pipeline value.

Dedika for businesses

What you will learn:

This course covers every stage of the pharmaceutical BD and licensing process, starting with drug development fundamentals and industry landscape analysis. You will learn how to value assets using rNPV models, conduct scientific and clinical due diligence, and source and screen external opportunities systematically. You will study how to structure licensing agreements, draft term sheets, and negotiate complex multi-party deals with confidence. The curriculum also addresses alliance management, portfolio strategy, regulatory considerations, IP fundamentals, and emerging deal structures including digital health and advanced therapeutic modalities. By the end, you will be equipped to contribute strategically to BD decisions at any stage of the pharmaceutical pipeline.

How you study in a practical way Pharma Business Development & Licensing Course

How you practice Pharma Business Development & Licensing Course

For companies who want to train their team

With Dedika for businesses, the course includes exercises and examples tailored to your own business and the way your company needs.

Click here

Course content

8 Chapters • 38 LessonsDuration between 4 and 360 hours (you decide)

Chapter 1See details

Foundations of Pharma Business Development

  • Lesson 1 • Role of Business Development

    Defines BD scope, distinguishing it from sales and marketing. Connects BD activities to corporate strategy and pipeline growth objectives.

  • Lesson 2 • The Pharma Industry Landscape

    Covers industry structure, key stakeholders, and market dynamics shaping BD decisions. Provides context for all subsequent deal-making and licensing concepts.

  • Lesson 3 • Drug Development Lifecycle Essentials

    Summarizes discovery through commercialization stages relevant to deal timing. Enables BD professionals to assess asset maturity and risk profiles.

  • Lesson 4 • Strategic Rationale for Partnerships

    Examines why companies pursue external innovation and collaboration. Links partnership rationale to portfolio strategy and resource constraints.

Chapter 2See details

Asset Valuation and Financial Fundamentals

  • Lesson 1 • Peak Sales and Market Sizing

    Develops bottom-up and top-down market sizing methodologies for drug assets. Directly feeds revenue assumptions into valuation models.

  • Lesson 2 • Core Financial Concepts for BD

    Introduces time value of money, cash flow modeling, and financial metrics essential for deal assessment. Grounds subsequent valuation techniques in financial theory.

  • Lesson 3 • Comparable Transaction Analysis

    Uses precedent deals to benchmark valuation assumptions and deal terms. Teaches systematic database research and comparables selection.

  • Lesson 4 • Risk-Adjusted NPV Modeling

    Applies probability of technical and regulatory success to NPV calculations. Produces rNPV models that reflect real-world asset uncertainty.

  • Lesson 5 • Deal Economics and Value Sharing

    Analyzes how deal structures allocate value between licensor and licensee. Connects financial modeling outputs to negotiation positioning.

Chapter 3See details

Opportunity Identification and Screening

  • Lesson 1 • Sourcing External Opportunities

    Maps channels for discovering licensing and partnership opportunities. Builds a proactive sourcing capability beyond inbound deal flow.

  • Lesson 2 • Initial Screening and Triage

    Applies rapid filters to prioritize opportunities for deeper evaluation. Prevents resource waste on poor-fit assets early in the funnel.

  • Lesson 3 • Strategic Fit and Portfolio Criteria

    Defines criteria linking external opportunities to internal portfolio gaps. Ensures screening decisions are anchored to corporate strategy.

  • Lesson 4 • Building a BD Opportunity Pipeline

    Establishes systems for tracking, managing, and reporting the opportunity funnel. Connects pipeline management to BD team performance metrics.

Chapter 4See details

Scientific and Clinical Due Diligence

  • Lesson 1 • Clinical Data Review and Interpretation

    Evaluates trial design, endpoints, safety signals, and efficacy data from clinical packages. Connects clinical findings to regulatory and commercial risk.

  • Lesson 2 • Due Diligence Process Design

    Structures the end-to-end due diligence workflow, team composition, and timeline. Sets the operational foundation for all subsequent diligence activities.

  • Lesson 3 • Competitive Landscape Analysis

    Maps the treatment landscape and pipeline competition to assess differentiation potential. Informs go/no-go recommendations and deal valuation.

  • Lesson 4 • Evaluating Preclinical Data Packages

    Assesses mechanism of action, in vitro and in vivo data quality, and translational relevance. Identifies scientific risks before clinical investment decisions.

  • Lesson 5 • Synthesizing Diligence Findings

    Integrates scientific, clinical, and competitive findings into a coherent risk-benefit summary. Prepares the BD team to present recommendations to decision-makers.

Chapter 5See details

Licensing Deal Structures and Term Sheets

  • Lesson 1 • Term Sheet Drafting and Review

    Applies deal structure knowledge to drafting and critiquing term sheets. Bridges conceptual understanding to practical document preparation.

  • Lesson 2 • Core Financial Deal Terms

    Details upfront fees, milestones, royalties, and minimum payments as deal components. Builds ability to construct and evaluate financial term packages.

  • Lesson 3 • Types of Licensing Arrangements

    Distinguishes exclusive, non-exclusive, co-exclusive, and sublicensable licenses. Connects license type selection to strategic and commercial objectives.

  • Lesson 4 • Alternative Deal Structures

    Explores co-development, co-promotion, option agreements, and asset acquisitions. Expands the BD professional's toolkit beyond standard licensing.

  • Lesson 5 • Non-Financial Deal Terms

    Examines governance, diligence obligations, IP ownership, and termination provisions. Ensures students recognize how non-financial terms affect deal value.

Chapter 6See details

Negotiation Strategy and Execution

  • Lesson 1 • Managing the Negotiation Process

    Addresses meeting management, documentation, and momentum maintenance across sessions. Ensures negotiations progress efficiently toward closure.

  • Lesson 2 • Negotiation Preparation and Planning

    Establishes pre-negotiation analysis including BATNA, priorities, and counterparty profiling. Preparation quality directly determines negotiation outcomes.

  • Lesson 3 • Negotiation Tactics and Techniques

    Covers anchoring, concession sequencing, packaging, and value creation tactics. Equips students to navigate competitive and collaborative negotiation dynamics.

  • Lesson 4 • Cross-Cultural Negotiation Dynamics

    Identifies cultural variables affecting communication, trust, and decision-making in global deals. Prepares students for international licensing negotiations.

  • Lesson 5 • Closing and Post-Negotiation Steps

    Covers final agreement confirmation, handoff to legal, and relationship transition. Ensures deal closure translates into effective partnership launch.

Chapter 7See details

Alliance Management and Partnership Governance

  • Lesson 1 • Alliance Evolution and Termination

    Manages partnership restructuring, expansion, and orderly termination scenarios. Ensures BD professionals can navigate the full alliance lifecycle.

  • Lesson 2 • Managing Alliance Conflict

    Identifies sources of partnership conflict and applies structured resolution approaches. Preserves relationship value while protecting contractual rights.

  • Lesson 3 • Governance Structures and Decision Rights

    Designs committee hierarchies, voting mechanisms, and escalation pathways for joint decisions. Clarifies authority to prevent operational gridlock.

  • Lesson 4 • Performance Monitoring and Reporting

    Tracks milestone progress, financial obligations, and diligence commitments across the alliance. Enables early detection of performance gaps.

  • Lesson 5 • Alliance Launch and Onboarding

    Establishes joint governance bodies, communication protocols, and shared workplans at deal inception. A strong launch prevents misalignment and conflict later.

Chapter 8See details

Advanced BD Strategy and Portfolio Management

  • Lesson 1 • Measuring BD Function Performance

    Defines KPIs and metrics for evaluating BD team effectiveness and deal quality. Enables data-driven improvement of the BD function over time.

  • Lesson 2 • Corporate Development and M&A Interface

    Clarifies the boundary and collaboration between BD licensing and M&A functions. Prepares BD professionals to contribute to acquisition processes.

  • Lesson 3 • Managing a Multi-Deal BD Portfolio

    Addresses simultaneous management of multiple active deals and alliances. Develops prioritization and resource management skills for BD leaders.

  • Lesson 4 • Portfolio Strategy and BD Alignment

    Links BD deal-making to portfolio-level objectives including balance, risk, and return. Ensures individual deals serve the broader strategic portfolio plan.

  • Lesson 5 • Build, Buy, Partner Decision Framework

    Applies structured criteria to choose between internal development, acquisition, and licensing. Integrates financial, strategic, and operational factors into the decision.

Certification

Your valid completion certificate

This course is for you:

  • BD analysts: ready to move from support tasks to owning deals independently.

  • Research scientists: exploring a transition into licensing or partnership roles.

  • Corporate strategy professionals: expanding their scope into pharma deal-making.

  • Regulatory affairs specialists: seeking to broaden their commercial and strategic impact.

  • Biotech founders: needing to negotiate licensing terms with larger pharma partners.

  • Management consultants: advising life sciences clients on transactions and partnerships.

What our students say

Your classes are perfect. I purchased the one-year package and finally have the opportunity to follow various topics of my interest without needing to change platforms... I thank you for everything you do, I've already recommended you to other people...
Giulio Carlo
Giulio CarloDigital Marketing Student
I like how the lessons are straight to the point and how I can switch chapters and skip content I don't need.
Mariana Ferres
Mariana FerresPhotography Student
I like the content and the way videos are presented and transcribed, which speeds up the process!
Luciana Alvarenga
Luciana AlvarengaNail Design Student
The platform is fast, simple to use. The diversity of content and complementary videos really help with learning.
André Felipe
André FelipePrompt Engineering Student

Top trainings

FAQs

Who is Dedika?

Is the certificate valid in the Philippines?

Are the courses free?

What is the course workload?

What are the courses like?

How do the courses work?

What is the duration of the courses?

What is the cost or price of the courses?

What is an EAD or online course and how does it work?

PDF Course